4 ms·

4% versus 2% in the longer term study. > Although this is pure randomness with such close measurements. That's not how this works at scale. We need larger stu

4% versus 2% in the longer term study. > Although this is pure randomness with such close measurements. That's not how this works at scale. We need larger studies, yes, but you can't simply dismiss a doubling of long-term symptom reports. At population scale, even a 1-2% incidence means millions of people.

anoncake 5y ago
There is no doubling here – only random noise.
unishark 5y ago
It is pretty weak though. There were only 109 seropositive kids in the follow-up according to the table, so you're talking about 2 more kids reporting a cough or headache as the entire basis of your concern.